神経症(Neuropathy)治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Neuropathy Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neuropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Neuropathy 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Neuropathy Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Sanofi 37
Clinical Trial Overview of Sanofi 37
NeurogesX, Inc. 38
Clinical Trial Overview of NeurogesX, Inc. 38
GW Pharmaceuticals plc 39
Clinical Trial Overview of GW Pharmaceuticals plc 39
Sumitomo Chemical Company, Limited 40
Clinical Trial Overview of Sumitomo Chemical Company, Limited 40
CSL Limited 41
Clinical Trial Overview of CSL Limited 41
Grunenthal GmbH 42
Clinical Trial Overview of Grunenthal GmbH 42
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
Baxter International Inc. 44
Clinical Trial Overview of Baxter International Inc. 44
Astellas Pharma Inc. 45
Clinical Trial Overview of Astellas Pharma Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
University of Texas M. D. Anderson Cancer Center 46
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 46
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
U.S. Department of Veterans Affairs 48
Clinical Trial Overview of U.S. Department of Veterans Affairs 48
Odense University Hospital 49
Clinical Trial Overview of Odense University Hospital 49
Columbia University 50
Clinical Trial Overview of Columbia University 50
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Washington University School of Medicine 52
Clinical Trial Overview of Washington University School of Medicine 52
National Center for Research Resources 53
Clinical Trial Overview of National Center for Research Resources 53
Rigshospitalet 54
Clinical Trial Overview of Rigshospitalet 54
Oregon Health & Science University 55
Clinical Trial Overview of Oregon Health & Science University 55
Five Key Clinical Profiles 56
Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Disclaimer 131
Source 131


【レポート販売概要】

■ タイトル:神経症(Neuropathy)治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Neuropathy Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2258CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。